Expired Tender Germany ICB TOT Ref. 31572065

Contract notice: Pharmaceutical products Tender in Germany - 31572065

Tender notice from Germany, published on 15 Mar 2019.

Executive Summary

The AOK BADEN-WÜRTTEMBERG has issued a Tender notice for the procurement of a Contract notice: Pharmaceutical products in the Germany. This Tender notice was published on 15 Mar 2019 and is scheduled to close on 24 Apr 2019, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 31572065, while the tender notice number is 121237-2019 and Register on the platform.

Key facts

Summary
Contract notice: Pharmaceutical products
TOT Ref. No.
31572065
Document Ref. No.
121237-2019
Country
Germany
Notice type
Tender
Competition
ICB
Publication date
15 Mar 2019
Bid deadline
24 Apr 2019
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
-
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Object of the contract
Pharmaceutical products
Description: Contract notice: Pharmaceutical products
Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union
Award criteria: Lowest price
CPV code: 33600000, 33696000, 33600000, 33696000
CPV Description:
Reagents and contrast media.
Conclusion of contracts for the supply of contrast agents in the consultation hours for the period from 1.10.2019 to 30.9.2021
Reference Number: GKVBW-2019-Contrast agent
The subject of this call for tenders is the conclusion of Contracts for the supply of radiologically active contract doctor practices in Baden-Wuerttemberg with contrast agents within the scope of consultation hours for the period from 1.8.2019 to 30.9.2021. The contracting party undertakes to ensure the supply of the contracted doctors in Baden-Wuerttemberg with the contrast agents agreed by the prescribed delivery contracts ("contracts") and the statutory health insurance for each delivered, contractual drugimittel a refund. According to -- 53 et seq. SGB X, the proposed contracts are used to stipulate reimbursement amounts of the successful tenderer (s), which are valid for the delivery of contrast agents, which are prescribed according to existing or future consultation hours requirement agreement at the expense of the client. According to the information given in Section II.2. 26 Fmade out of axles. Each or each of the ATC code or ATC code subgroup named in the tray lots forms its own tray. Trays without further subdivision are denoted by a letter. In case of a further subdivision of a special lot, an additional number will be indicated (partial).
Reference is made to the brief description of the subject of the contract (see point II.1.4) and in particularto the following:
A total of 3 partial lots are formed for the active substance amidotrizoic acid. The medicinal products of the ATC code contain different salts or combinations of different salts of the active substance, since otherwise the comparability would be difficult.
Lot-Nr. A1 concerns the Teillos 1. In this subject lot only contrast agents with the active ingredient Amidotrizoeacid, which contains the salt L-lysine amidotrizoat, demanded. The product is administered by oral and rectal administration.
The tenderer must submit a single European self-declaration. Tenderers must submit for each Member a separate Single European Statement, which is completed in Parts II, III, IV and VI.
BietContracting entities using third parties to secure delivery capacity must also, upon separate request, in accordance with the terms of reference of the tender documents, issue a separate single European self - declaration containing the relevant information (see Part II, Section C of the standard form for the Single European Self - declarationAnnex 2 to Commission Implementing Regulation (EU) 2016/7) for each of the third parties used to secure the supply capacity. It should be noted that also companies affiliated with the bidder i. S. of group law can be third-party companies ("other companies" in the sense of - 47 para 1 VgV).
The contracting authorities can bid/ Bietergemeinschaften at any time to provide all or part of the proof of eligibility to prove suitability, if this is necessary for the proper implementation of the procedure (- 50 para 2 sentence 1 VgV).
Before the contract is awarded on request of the client (- 50 Abs 2 sentence 2 VgV), the following proofs of suitability are requiredunder section B.II. the conditions of application:
- a single copy from the commercial register (not earlier than 1.11.2018); foreign bidders are required to produce a corresponding copy / excerpt from the professional or commercial register in accordance with the legislation of the state in which they are resident,
- copy of the wholesale permit in accordance with - 52a AMG or Art.77 RL 2001/83 / EC or a copy of the manufacturing license in accordance with - 13 AMG or Art. 40 RL 2001/83 / EC, which covers the contrast-enhancing contrast media, or a copy of the import permit pursuant to - 72 AMG or - 40 (3) Directive 2001/83 / EC, which covers the contrast media available,
- a health insurance certificate attesting that the tenderer has not fulfilled his contractpayment of social security contributions in accordance with the relevant legislation; this proof may not be older than from 1 November 2018; Foreign bidders must provide the required document by means of appropriate certification in accordance with the legislation of the State in which the company is establishedin accordance with Annex 5 to the conditions of application (see section B.II.1 of the conditions of application) and
- in the case of the use of third-party undertakings whose supply capacity is to be used: Single European Self-declaration (EEE) 50 VgV i. V. m. Commission Implementing Regulation (EU) 2016/7 of 5 January 20116 of each third party and third party undertakings pursuant to Annexes 6a / 6b; - for consortia, at the request of a separate consortium, a declaration of intent on the admission of a consortium; Furthermore, there are special features in accordance with section B.II.3. the conditions of application.
Announcement ID: CXP4YH0Y8DF
Internet address (URL): https://bw.aok.de/

Documents

Tender Notice
Login to view

Similar tenders

Germany Public Procurement Intelligence

Frequently asked questions

The bid deadline for Contract notice: Pharmaceutical products was 24 Apr 2019. Bidding is closed.

This tender has been issued by AOK BADEN-WÜRTTEMBERG in Germany.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products, 33696000 - Reagents and contrast media.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 31572065. The purchaser document reference is 121237-2019.

See the Similar Tenders section on this page or browse other tenders from Germany.

This tender falls under Materials and Products in Germany. Suppliers in these sectors can track similar Germany tenders using CPV-based alerts.